Kynam Capital Management’s Cogent Biosciences COGT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$155M	Sell	4,037,331 -2,127,892	-35%	-$78.6M	9.59%	4
2025 Q4	$219M	Sell	6,165,223 -1,720,949	-22%	-$48.4M	13.99%	1
2025 Q3	$113M	Sell	7,886,172 -606,385	-7%	-$7.18M	8.43%	4
2025 Q2	$61M	Sell	8,492,557 -612,443	-7%	-$3.4M	6.56%	8
2025 Q1	$54.5M	Hold	9,105,000	–	–	4.58%	9
2024 Q4	$71M	Sell	9,105,000 -134,731	-1%	-$1.34M	4.2%	8
2024 Q3	$99.8M	Sell	9,239,731 -20,654	-0.2%	-$201K	7.65%	5
2024 Q2	$78.1M	Buy	9,260,385 +760,385	+9%	+$5.77M	6.02%	7
2024 Q1	$57.1M	Buy	8,500,000 +2,645,234	+45%	+$16.4M	5.98%	5
2023 Q4	$34.4M	Buy	5,854,766 +3,644,641	+165%	+$27.9M	3.81%	9
2023 Q3	$21.5M	Buy	2,210,125 +592,734	+37%	+$7.03M	3.52%	10
2023 Q2	$19.1M	Buy	1,617,391 +1,217,417	+304%	+$14M	2.63%	11
2023 Q1	$4.32M	Sell	399,974 -394,075	-50%	-$5.04M	0.56%	23
2022 Q4	$9.18M	Sell	794,049 -191,106	-19%	-$2.37M	1.41%	15
2022 Q3	$14.7M	Sell	985,155 -14,845	-1%	-$203K	3.1%	12
2022 Q2	$9.02M	Buy	+1,000,000	New	+$6.83M	2.3%	13
2022 Q1	–	Sell	-150,000	Closed	-$1.29M	–	35
2021 Q4	$1.29M	Buy	+150,000	New	+$1.3M	0.69%	27